Correlation Between Blueprint Medicines and Black Diamond
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Black Diamond Therapeutics, you can compare the effects of market volatilities on Blueprint Medicines and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Black Diamond.
Diversification Opportunities for Blueprint Medicines and Black Diamond
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Blueprint and Black is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Black Diamond go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Black Diamond
Given the investment horizon of 90 days Blueprint Medicines is expected to generate 1.58 times less return on investment than Black Diamond. But when comparing it to its historical volatility, Blueprint Medicines Corp is 3.64 times less risky than Black Diamond. It trades about 0.07 of its potential returns per unit of risk. Black Diamond Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 248.00 in Black Diamond Therapeutics on November 9, 2024 and sell it today you would earn a total of 4.00 from holding Black Diamond Therapeutics or generate 1.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Black Diamond Therapeutics
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Black Diamond Therap |
Blueprint Medicines and Black Diamond Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Black Diamond
The main advantage of trading using opposite Blueprint Medicines and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |